Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
<h4>Background</h4>Cryptococcal meningitis accounts for 15% of AIDS-related mortality. Cryptococcal antigen (CrAg) is detected in blood weeks before onset of meningitis, and CrAg positivity is an independent predictor of meningitis and death. CrAg screening for patients with advanced HIV...
Main Authors: | Radha Rajasingham, David B Meya, Gregory S Greene, Alexander Jordan, Mina Nakawuka, Tom M Chiller, David R Boulware, Bruce A Larson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0210105 |
Similar Items
-
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
by: Radha Rajasingham, et al.
Published: (2012-01-01) -
Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.
by: Richard Kwizera, et al.
Published: (2014-01-01) -
Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
by: Radha Rajasingham, et al.
Published: (2014-04-01) -
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana [version 2; peer review: 2 approved]
by: Mark W. Tenforde, et al.
Published: (2020-03-01) -
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana [version 1; peer review: 2 approved]
by: Mark W. Tenforde, et al.
Published: (2019-09-01)